Literature DB >> 24481540

Impact of sleep-disordered breathing on myocardial damage and metabolism in patients with chronic heart failure.

Makiko Miyata1, Akiomi Yoshihisa, Hiroyuki Yamauchi, Takashi Owada, Takamasa Sato, Satoshi Suzuki, Koichi Sugimoto, Takayoshi Yamaki, Hiroyuki Kunii, Kazuhiko Nakazato, Hitoshi Suzuki, Shu-Ichi Saitoh, Yasuchika Takeishi.   

Abstract

Sleep-disordered breathing (SDB) has a critical association with mortality and morbidity of patients with chronic heart failure (CHF). Troponin T is a marker of ongoing myocardial damage and predicts adverse clinical outcomes in patients with CHF. Carnitine plays an important role in the utilization of fatty acids in the myocardium. It has been reported that myocardial carnitine levels decrease in the failing heart. We hypothesized that plasma troponin T and carnitine are increased due to the leakage from damaged cardiomyocytes or the alteration of myocardial metabolism in CHF patients with SDB. We examined the relation of plasma troponin T and carnitine levels with severity of SDB in CHF. We used portable sleep monitor and measured the apnea-hypopnea index (AHI), plasma levels of high-sensitive troponin T and carnitine in 131 CHF patients. These patients were divided into three groups based on AHI: group A (None-mild SDB AHI < 15/h, n = 45), group B (Moderate SDB 15 ≤ AHI < 30/h, n = 32) and group C (Severe SDB AHI ≥ 30/h, n = 54). Levels of high-sensitive troponin T and plasm total carnitine were significantly higher in group C than in groups A and B [high-sensitive troponin T; group A 0.009 (0.005-0.016), group B 0.012 (0.006-0.021), group C 0.021 (0.011-0.039) ng/ml, total carnitine; group A 61.0 ± 15.1, group B 65.0 ± 13.5, group C 73.3 ± 17.5 μmol/l, P < 0.01 vs. group A and P < 0.05 vs. group B, respectively]. Furthermore, in the multiple regression analysis, the independent factors to determine plasma levels of log (high-sensitive troponin T) were high-sensitive C-reactive protein and AHI, and the independent factors to determine plasma levels of carnitine were glomerular filtration rate and AHI. The present study suggests that SDB is associated with latent myocardial damage and alteration of myocardial carnitine metabolism in patients with CHF, presented by higher circulating troponin T and carnitine levels.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481540     DOI: 10.1007/s00380-014-0479-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.

Authors:  Serge Masson; Inder Anand; Chiara Favero; Simona Barlera; Tarcisio Vago; Federico Bertocchi; Aldo P Maggioni; Luigi Tavazzi; Gianni Tognoni; Jay N Cohn; Roberto Latini
Journal:  Circulation       Date:  2011-12-02       Impact factor: 29.690

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  Nocturnal urinary protein excretion rates in patients with sleep apnea.

Authors:  A H Sklar; B A Chaudhary; R Harp
Journal:  Nephron       Date:  1989       Impact factor: 2.847

Review 4.  L-carnitine--metabolic functions and meaning in humans life.

Authors:  Jolanta Pekala; Bozena Patkowska-Sokoła; Robert Bodkowski; Dorota Jamroz; Piotr Nowakowski; Stanisław Lochyński; Tadeusz Librowski
Journal:  Curr Drug Metab       Date:  2011-09       Impact factor: 3.731

5.  Sleep-disordered breathing in obese adolescents is associated with visceral adiposity and markers of insulin resistance.

Authors:  Tamara S Hannon; Sojung Lee; Sangeeta Chakravorty; Yan Lin; Silva A Arslanian
Journal:  Int J Pediatr Obes       Date:  2010-06-14

6.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

7.  The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea.

Authors:  Selma Firat Guven; Mustafa Hamidullah Turkkani; Bulent Ciftci; Tansu Ulukavak Ciftci; Yurdanur Erdogan
Journal:  Sleep Breath       Date:  2011-02-18       Impact factor: 2.816

8.  L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms.

Authors:  Ali Reza Serati; Mohammad Reza Motamedi; Sepideh Emami; Peyman Varedi; Mohammad Reza Movahed
Journal:  Cardiology       Date:  2010-07-16       Impact factor: 1.869

9.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

10.  Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport.

Authors:  L J Waber; D Valle; C Neill; S DiMauro; A Shug
Journal:  J Pediatr       Date:  1982-11       Impact factor: 4.406

View more
  10 in total

1.  Heterogenous haemodynamic effects of adaptive servoventilation therapy in sleeping patients with heart failure and Cheyne-Stokes respiration compared to healthy volunteers.

Authors:  Jens Spießhöfer; Henrik Fox; Roman Lehmann; Christina Efken; Jessica Heinrich; Thomas Bitter; Britta Körber; Dieter Horstkotte; Olaf Oldenburg
Journal:  Heart Vessels       Date:  2015-08-22       Impact factor: 2.037

Review 2.  Biomarkers in Sleep Apnea and Heart Failure.

Authors:  Ying Y Zhao; Reena Mehra
Journal:  Curr Heart Fail Rep       Date:  2017-08

3.  Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.

Authors:  Yoko M Nakao; Kenji Ueshima; Shinji Yasuno; Shigetake Sasayama
Journal:  Heart Vessels       Date:  2014-10-28       Impact factor: 2.037

4.  Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.

Authors:  Keitaro Akita; Yuichiro Maekawa; Takashi Kohno; Hikaru Tsuruta; Mitsushige Murata; Keiichi Fukuda
Journal:  Heart Vessels       Date:  2017-05-29       Impact factor: 2.037

5.  Linkage of sleep-disordered breathing and acute aortic dissection with patent false lumen.

Authors:  Toru Inami; Yoshihiko Seino; Tetsuro Shimura; Osamu Kurihara; Nakahisa Kimata; Daisuke Murakami; Ryo Munakata; Masamichi Takano; Takayoshi Ohba; Wataru Shimizu
Journal:  Heart Vessels       Date:  2015-06-26       Impact factor: 2.037

Review 6.  Heart failure and sleep disordered breathing.

Authors:  Akiomi Yoshihisa; Yasuchika Takeishi
Journal:  Fukushima J Med Sci       Date:  2017-07-21

7.  Patients with Cheyne-Stokes respiration and heart failure: patient tolerance after three-month discontinuation of treatment with adaptive servo-ventilation.

Authors:  Arild Hetland; Tøri Vigeland Lerum; Kristina H Haugaa; Thor Edvardsen
Journal:  Heart Vessels       Date:  2017-02-11       Impact factor: 2.037

8.  Untreated Obstructive Sleep Apnea Is Associated With Myocardial Injury Independent of Blood Pressure Control in Hypertension.

Authors:  Macy M S Lui; H F Tse; Judith C W Mak; David C L Lam; Carmen W S Chan; Peony W C Chong; Mary S M Ip
Journal:  J Clin Sleep Med       Date:  2018-11-15       Impact factor: 4.062

9.  Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children.

Authors:  Yuwen Wang; Yi Xu; Runmei Zou; Lijia Wu; Ping Liu; Hong Yang; Zhenwu Xie; Cheng Wang
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

10.  Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.

Authors:  Akiomi Yoshihisa; Yu Sato; Yuki Kanno; Mai Takiguchi; Tetsuro Yokokawa; Satoshi Abe; Tomofumi Misaka; Takamasa Sato; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Open Heart       Date:  2020-04-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.